To evaluate a possible selective gain-of-function of mutant PLXNA1 signaling in pancreas cancer, PLXNA1 was silenced in both SB.06 and SB.07 cells via introduction of PLXNA1 siRNA. The gene discussed is PLXNA1; the disease is pancreatic neoplasm.